Olivia joined Newmarket Strategy in 2025, bringing several years of experience in life sciences consulting, where she partnered with global pharmaceutical clients to design and implement R&D, clinical development, and organisational strategies.
She has advised clients on a broad range of strategic and operational challenges spanning clinical research, regulatory affairs, digital transformation, and organisational effectiveness. Olivia is adept at managing cross-functional projects and translating complex analysis into clear, actionable recommendations that drive measurable impact.
As a Prosci-certified change practitioner, she has led large-scale change and engagement programmes, building senior stakeholder alignment and embedding new ways of working across diverse teams.
Olivia holds a Master’s degree in Cancer Research and Precision Medicine from the University of Glasgow.